Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine
DAN-COVID
Approved small_molecule active
Quick answer
Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine for SARS-CoV-2 infection is a Approved program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moderna Biotech Spain
- Indication
- SARS-CoV-2 infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- active